Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Obesity 1

Interventions

Cyclophosphamide 637Bevacizumab 552Paclitaxel 533Carboplatin 531Cisplatin 478pembrolizumab 452Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 371Dexamethasone 349Doxorubicin 325Nivolumab 307Fluorouracil 286Capecitabine 260Prednisone 243Oxaliplatin 242Erlotinib Hydrochloride 242Etoposide 239Lenalidomide 231Cytarabine 230Trastuzumab 227Pemetrexed 219fludarabine phosphate 207Vincristine 207Leucovorin 207Cetuximab 207Filgrastim 204Bortezomib 191Methotrexate 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Has results × Weight Reduction Programs × Clear all
NCT03261271 2025-04-13

WARRIOR

University of Kansas Medical Center

Phase NA Completed
40 enrolled 19 charts
GenitourinaryOther

Obesity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡